Physician profile
Steven B Morgan
NPI 1336149640
$10,503.61
in general payments reported to CMS, 2019-2025
14 companies · $92.06 in 2025
The $92.06 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,053 · 2020: $425 · 2021: $1,390 · 2022: $138 · 2023: $1,303 · 2024: $6,102 · 2025: $92.06.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $5,800 · Travel and Lodging: $849 · Food and Beverage: $849.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $5,800.00 |
| Travel and Lodging | $848.96 |
| Food and Beverage | $848.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kyocera Medical Technologies, INC. | $5,963.99 | 2024 | |
| Pylant Medical | $1,453.13 | 2020-2025 | |
| Arthrex, INC. | $1,107.96 | 2023 | |
| Medacta USA, INC. | $782.12 | 2019 | |
| Conformis, INC. | $244.19 | 2020 | |
| Stryker Corporation | $187.21 | 2020-2022 | |
| Vericel Corporation | $148.86 | 2021-2024 | Maci |
| Globus Medical, INC. | $135.15 | 2019 | |
| Smith+Nephew, INC. | $122.94 | 2019 | |
| Depuy Synthes Sales INC. | $116.81 | 2021-2025 | Orthovisc, Monovisc |
| Horizon Therapeutics Plc | $82.94 | 2019-2021 | |
| Bioventus LLC | $75.47 | 2023-2025 | Durolane, Durolane |
| Orthofix Medical, INC. | $68.20 | 2023-2024 | Physio-Stim |
| Zimmer Biomet Holdings, INC. | $14.64 | 2024 | Gps III Platelet Concentration System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Morgan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.